PRIMARY HYPERCHOLESTEROLEMIA OR MIXED HYPERLIPIDEMIA
Clinical trials for PRIMARY HYPERCHOLESTEROLEMIA OR MIXED HYPERLIPIDEMIA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY HYPERCHOLESTEROLEMIA OR MIXED HYPERLIPIDEMIA trials appear
Sign up with your email to follow new studies for PRIMARY HYPERCHOLESTEROLEMIA OR MIXED HYPERLIPIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New shot could help millions with stubborn high cholesterol
Disease control Not yet recruitingThis study tests an investigational drug called QLC7401 for people with high cholesterol that remains high despite taking standard cholesterol-lowering medications. About 780 adults will receive either the study drug or a placebo as a shot under the skin. The goal is to see if QL…
Matched conditions: PRIMARY HYPERCHOLESTEROLEMIA OR MIXED HYPERLIPIDEMIA
Phase: PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 10:09 UTC
-
New shot could help control stubborn cholesterol
Disease control Not yet recruitingThis study tests a new medicine called QLC7401 in adults with high cholesterol or mixed dyslipidemia who are not on other treatments. Participants receive injections of either the drug or a placebo to see if it safely lowers bad cholesterol. The goal is to manage cholesterol leve…
Matched conditions: PRIMARY HYPERCHOLESTEROLEMIA OR MIXED HYPERLIPIDEMIA
Phase: PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 10:07 UTC